(NYSE: STE) Steris's forecast annual revenue growth rate of 6.33% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.39%.
Steris's revenue in 2025 is $5,459,515,000.On average, 4 Wall Street analysts forecast STE's revenue for 2026 to be $573,139,506,947, with the lowest STE revenue forecast at $569,835,377,798, and the highest STE revenue forecast at $577,591,050,719. On average, 4 Wall Street analysts forecast STE's revenue for 2027 to be $603,475,658,277, with the lowest STE revenue forecast at $596,063,403,091, and the highest STE revenue forecast at $609,288,576,447.
In 2028, STE is forecast to generate $650,409,382,495 in revenue, with the lowest revenue forecast at $650,408,595,516 and the highest revenue forecast at $650,410,169,473.